Scientists Find an Unusual Weapon Against Virus
Boosting Weak Immune System
Some viruses can be dormant throughout a person’s life and cause no harm but become dangerous when the immune system is weakened. One of such viruses is human cytomegalovirus (CMV). Harmless to the general public but life-threatening to patients with a supressed immune system.
“Patients undergoing bone marrow transplantations have their blood and immune system fully replaced by that of the donor. In the first months after transplantation they are defenseless. They can either catch CMV or have virus reactivated that was dormant in the patient. At the moment, there is no ideal treatment. The available ones work in a limited way or can cause severe side effects such as kidney failure, liver failure, deafness, sepsis, and others,” explains Dr. Julien Subburayalu, a clinical scientist in the Sieweke group at the Center for Regenerative Therapies Dresden (CRTD), one of the leading authors of the study.
The Unusual Approach: Boosting Immune System
Teaming up with Dr. Marc Dalod, an expert on CMV immunity, the researchers led by Prof. Sieweke took an unusual approach. Instead of targeting the virus with antiviral treatments, they focused on strengthening the immune system to fight the virus on its own.
“So far, antiviral treatments focused on targeting specific viruses, either through vaccination or by drugs that work on viral molecular machinery,” mentions Dr. Marc Dalod, group leader at the Centre d’Immunologie de Marseille-Luminy (CIML) and author of the study. “Our method intervenes at the level of patient’s blood stem cells to boosts general antiviral defenses. It’s ideal as a prophylactic or a general intervention strategy in immunosuppressed individuals,” says Prof. Michael Sieweke, Alexander von Humboldt Professor and research group leader at the CRTD and CIML.
Cytokine: Small but Mighty Molecule
The new approach focuses on the cytokine known as macrophage colony-stimulating factor (M-CSF, CSF1). It’s a small signaling molecule that works as a messenger and activator for the immune system. “The cytokine boosts the production of specific white blood cells, mainly monocytes and macrophages,” says Dr. Prashanth Kumar Kandalla, one of the leading authors of the study.
Although normally monocytes and macrophages were not known as the primary defense force against viruses, the authors found that they activated other immune cells, so-called natural killer cells, that help fight the virus. “In case of immunocompromised patients, the number of white blood cells is very low. This is why their body is defenseless against infections. M-CSF treatment would boost the immune system by triggering the production of new white blood cells and restore the patient’s ability to fight the pathogen,” explains Dr. Kandalla.
The team could show that M-CSF boosted production of white blood cells in immunocompromised mice and in such a way protected them from an otherwise lethal CMV infection without affecting bone marrow transplantation.
Clinical Trials Are Needed
The study showed that the concept worked in mice and in human cells in a culture dish. “We are keen to expand our findings and support them with data derived from patients in the clinic. For example, we would like to test our cytokine approach as a prophylactic intervention following bone marrow transplantation to prevent CMV reactivation. For this, clinical trials are necessary. We are now looking for partners who could help us finance such trials,” concludes Prof. Sieweke.
Because of its unique ability to boost the immune defence, the new approach is not limited to CMV or bone marrow transplantation patients. The authors expect that it could also be useful to treat other viral infections, and help other patients with a weakened immune system, for example after sepsis or chemotherapy.
Other news from the department science
A new approach to recording cellular activities
Potential for accelerating research: A novel chemical labeling method allows transient events in cells to be recorded for later analysis
Scientists deliver portable total chemical analysis without pumps and tubes
The portability of the new device enables bedside, quantitative clinical analysis or environmental analysis in the field
99 million people included in largest global COVID-19 vaccine safety study
Global Vaccine Data Network utilises vast data sets to detect potential vaccine safety signals
Graphene research: numerous products, no acute dangers
Successful completion of the EU Graphene Flagship
Powering Nitrogenases: New ways for sustainable fertiliser production
New targets for improving biocatalysts
Using metabolomics for assessing safety of chemicals may reduce the use of lab rats
"We hope that learnings from this research will be included in new guidance for the chemical industry to allow commercial laboratories to provide these services widely"
Revolutionary cell therapy: rebooting the immune system stops autoimmune diseases
Single infusion of CAR-T cells replaces immunosuppressive drugs
Cracking the Code of Neurodegeneration: New Model Identifies Potential Therapeutic Target
Novel neural cell culture model developed
IQ does not remain the same throughout life
A meta-study shows that an intelligence quotient measured once is not necessarily meaningful later on
New mechanism for regulating cell division in the bacterial pathogen Klebsiella uncovered
Small ribonucleic acid with a big impact
More brain than trait: Decoding the neural pathways of curiosity
Discovery sheds new light on the biological basis of human curiosity and could have far-reaching implications for the understanding and treatment of diseases
What Our Genetic Information Tells Us About Type 2 Diabetes Risk and Complications
Largest Study on Genetic Risk for Diabetes Now Published
Study Proposes Framework to Standardize Biomarkers of Aging and Accelerate Clinical Use
Improving the life expectancy and health of the population
Researchers succeeded in biomanufacturing using chemically synthesized sugar for the first time in the world
Biomanufacturing using chemically synthesized sugars enables sustainable supply of sugar without competing with food
Most read news
The secret of whales: How giant whales defy cancer
Study of gigantism in whales provides clues to genomic mechanism involved in tumor suppression
mRNA therapeutic successfully combats ovarian cancer
The mRNA therapeutic successfully combated cancerous cells and tumors in vitro as well as metastases in mice
Microbe of the Year 2023: Bacillus subtilis – for health and technology
Already, Bacillus subtilis is indispensable in many industries, and many more innovations are expected
A standard blood test can predict a heart attack
Using the results of a standard blood test and an online tool, you can find out if you are at increased risk of having a heart attack within six months
Making Ends Meet: Researchers Find That a Protein Superglue is Crucial for DNA Damage Repair
New Understanding for Cancer Treatments
Learning from Nature: How a fungus makes a hard job easier
Researchers analyze a fungal biosynthetic pathway and discover a capable enzyme
Innovative microscopy technique reveals secrets of lipid synthesis inside cells
Two-color infrared photothermal microscopy (2C-IPM) opens new avenues for long-term study of lipid metabolism in living cells
Artificial cartilage with the help of 3D printing
New approach to producing artificial tissue works with cells in microstructures from the 3D printer
Destroying Tumor Cells with Calcium
Activating calcium channels leads to a deadly influx of calcium ions into tumor cells
Pregnant women should avoid ultraprocessed, fast foods
Curiously, it’s not the food that the study targets but what touches the food before you eat it
Swiss longevity biotech receives support from L'Oréal and Nestlé
Timeline Secures Pivotal Financing Round
More news from our other portals
Planned EU legislation on packaging threatens popular seasonal confectionery
Federal Association of the German Confectionery Industry fears the end of chocolate Easter bunnies & Co.
Mystery of Novel Clove-Like Off-Flavor in Orange Juice Solved
Tracking down off-flavours using techniques such as gas chromatography-olfactometry and aroma extract dilution analysis
Green steel from toxic red mud
An economical process with green hydrogen can be used to extract CO2-free iron from the red mud generated in aluminium production
BASF and Envision Energy enter a collaboration to drive sustainable energy solutions
Collaboration to accelerate conversion of green hydrogen and CO2 to e-methanol
Eckes-Granini further expands important out-of-home business segment
Market share gains and double-digit sales growth in 2023
Chemists are on the hunt for the other 99 percent
New mass spectrometry combo offers promise for tapping nature’s unknown chemical universe
GPT-3 for chemical research
Researchers develop fast and user-friendly language model for chemical tasks
Microgreens made to order
Italian scientists have tailored iodine and potassium content of radishes, peas, rocket and chard
Revolutionizing batteries: Coffee grounds power high-performance sodium-ion anodes
Using coffee waste as a precursor material for hard carbon synthesis
Greetings from the island of enhanced stability: The quest for the limit of the periodic table
A fresh view on new superheavy elements
Detect 'forever chemicals' in under 3 minutes
New lab-based method to detect traces of PFAS from food packaging material, water and soil samples
Celebrate carnival and do good with gin: Lost Sisters Limited Dry Gin
Lost Sisters Edition aims to generate 11,110 euros in donations with gin de cologne during the carnival season
Ferrero Group continues its growth trajectory
The Group expanded its presence in North America with the strategic acquisition of ice cream maker Wells Enterprises Inc.